Company overview
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company sells and markets its products in the United States, Canada, the United Kingdom, Ireland, Spain, Portugal, France, Belgium, Luxemburg, Italy, Germany, Austria, Japan, Australia, and India through distributors. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokne'am, Israel.
Daily valuation snapshot
These values come from the daily market snapshot dated 2026-10-08. TTM means trailing twelve months. Use the market date when comparing INMD with another company.
| Daily close (USD) | $14.08 |
| Market capitalization (USD) | $810,221,941.76 |
| Price / earnings (TTM) | 8.63 |
| Price / book | 1.19 |
No matching rows. Clear the filter to see all records.
Read INMD's valuation metrics
Company size
InMode Ltd. Ordinary Shares's recorded market capitalization is $810,221,941.76. It measures the market value of the company's equity, rather than its revenue or cash balance.
Price relative to earnings
INMD's recorded P/E is 8.63: about $8.63 of share price for each $1 of trailing annual earnings per share. Compare that multiple with earnings growth and companies in the same business.
Price relative to book equity
INMD's recorded price-to-book ratio is 1.19. That compares its market equity value with recorded book equity. Examine its business and balance sheet to understand why those values differ.
Research InMode Ltd. Ordinary Shares with Aurora
Use the snapshot above to ask a specific question about INMD. Ask for the report period and the figures behind the explanation, then compare the answer with the company's business description.
Continue the research
Follow INMD's ownership disclosures to see who filed a transaction or position and when it became public. To turn a research idea into a strategy, define an entry rule and test its dated observations.